In particular, we found that AIM2 inflammasome is activated in exacerbated/unstable COPD-derived PBMCs and leads to IL-1α and TGF-β release in a caspase-1- and caspase-4-dependent manner. The gene discussed is AIM2; the disease is chronic obstructive pulmonary disease.